AlzBiomarker
MCI-AD vs MCI-Stable: Aβ38 (CSF)
Baseline levels of Aβ38 in the cerebrospinal fluid were marginally elevated in people with mild cognitive impairment who went on to develop Alzheimer’s dementia versus those who did not progress at follow-up (effect size = 1.127, p = 0.01). The analysis is limited to two eligible comparisons.
Loading data...